Developing Effective Cell- and Gene-Based Therapies.

New techniques for clinical use in treating regenerative, immunomodulatory and anti-fibrotic settings for a range of disease conditions. v

University of Birmingham logo
About University of Birmingham
At the University of Birmingham our research leads to new invenons and fuels innovaon and business growth.

Background.

The University of Birmingham has developed a state-of-the-art GMP Manufacturing Suite for Advanced Therapies development.
Licensed by the MHRA for the manufacture of Advanced Therapy Medicinal Products (ATMP) for clinical use, experts within the Advanced Therapies Facility (ATF) also benefit from a Specials licence allowing the manufacture of products for use in selected patients outside of clinical trial settings. The ATF is situated adjacent to the NIHR/Wellcome Trust Clinical Research Facility, where manufactured products can be administered to patients in an appropriate clinical environment.
Through collaborative research with partners and clients the Facility strives to further the development of effective cell-, tissue- and gene-based therapies, in a predominantly clinical trial environment.

Make An Enquiry.